Mishcon de Reya page structure
Site header
Main menu
Main content section

Inside Life Sciences

Issue 12: November 2020

Inside Life Sciences

Editor's Note

Welcome to the Autumn edition of Inside Life Sciences.


MHRA guidance on post-transition Brexit regulation of medical devices.

With the end of the transition period looming, and the UK/EU still in discussions in relation to a possible trade deal, the UK Government has published guidance in relation to the requirements for placing medical devices on the market in Great Britain (England, Scotland and Wales), Northern Ireland and the EU after 1 January 2021.


European Court finds that CBD is not a narcotic

The European Court of Justice has ruled that a particular form of CBD, derived from industrial hemp, is not a narcotic as “it does not appear to have any psychotropic effect or any harmful effect on human health”. This judgment from the EU's highest court is undoubtedly positive for the CBD industry.


EMA encourages transparency through new monthly report on COVID-19 medicines and vaccines

In a bid to support the ongoing assessment, monitoring and transparency of medicines and vaccines in the fight against the spread of COVID-19, the European Medicines Agency (EMA) is publishing a monthly report detailing scientific advice and informal consultation details relating to COVID-19 medicines and vaccines reviewed by the COVID-19 EMA pandemic Task Force.

abstract lights on dark background

ICO Innovation Hub and the MHRA

The Information Commissioner's Office (ICO) set up the Regulator's Business Innovation Privacy Hub (the Innovation Hub) in November 2018 to provide, in partnership with other regulators, expert support to businesses in information privacy and data protection.

Previous Issues

How can we help you?

How can we help you?

Subscribe: I'd like to keep in touch

If your enquiry is urgent please call +44 20 3321 7000

Crisis Hotline

I'm a client

I'm looking for advice

Something else